Total time from first Phase 3 enrollment to approval: roughly 3 years
In an osteoarthritis model, a single liraglutide injection decreased synovitis and pain sensitivity, without affecting body weight
Diabetes Care 39 , 222230 (2016) L.A
For context, the semaglutide journey from Phase 3 initiation to market availability in smaller European markets took roughly 45 years
Ozempic is about to be old news, my colleague Yasmin Tayag wrote in 2023, just before an even more powerful obesity drug, tirzepatide, then best known as Mounjaro, was approved
can help explain why these medications are transforming obesity treatment and metabolic health